Drug Delivery

Papers
(The H4-Index of Drug Delivery is 41. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Oral delivery of the intracellular domain of the insulinoma-associated protein 2 (IA-2ic) by bacterium-like particles (BLPs) prevents type 1 diabetes mellitus in NOD mice199
Immunomodulatory nano-preparations for rheumatoid arthritis184
Acoustic triggered nanobomb for US imaging guided sonodynamic therapy and activating antitumor immunity179
Rapid oral transmucosal delivery of zaleplon–lavender oil utilizing self-nanoemulsifying lyophilized tablets technology: development, optimization and pharmacokinetic evaluation149
Luteolin-loaded exosomes derived from bone marrow mesenchymal stem cells: a promising therapy for liver fibrosis135
Exploring the effects of cannabidiol encapsulation in liposomes on their physicochemical properties and biocompatibility134
Recent progress in nanotechnology-based drug carriers for resveratrol delivery130
Advanced hydrogel material for colorectal cancer treatment111
The development and evaluation of hyaluronic acid coated mitochondrial targeting liposomes for celastrol delivery92
Oral liposomal delivery of an activatable budesonide prodrug reduces colitis in experimental mice87
Transdermal delivery of colchicine using dissolvable microneedle arrays for the treatment of acute gout in a rat model73
Hyaluronic acid-based nanoparticles to deliver drugs to the ocular posterior segment70
Functional ligands for improving anticancer drug therapy: current status and applications to drug delivery systems69
Alginate-based aerogels as wound dressings for efficient bacterial capture and enhanced antibacterial photodynamic therapy61
Co-delivery of amphotericin B and pentamidine loaded niosomal gel for the treatment of Cutaneous leishmaniasis61
Development of microparticles for oral administration of Periplaneta americana extract to treat ulcerative colitis60
Thermo-sensitive self-assembly of poly(ethylene imine)/(phenylthio) acetic acid ion pair in surfactant solutions57
Effect of pH-sensitive nanoparticles on inhibiting oral biofilms57
The discovery of berberine erythrocyte-hemoglobin self-assembly delivery system: a neglected carrier underlying its pharmacokinetics56
Pitavastatin-loaded bilosomes for oral treatment of hepatocellular carcinoma: a repurposing approach54
Effect and mechanism of paclitaxel loaded on magnetic Fe 3 O 4 @mSiO 2 -NH 253
Surface functionalized nanomaterial systems for targeted therapy of endocrine related tumors: a review of recent advancements51
Quantitative analysis of therapeutic proteins in biological fluids: recent advancement in analytical techniques50
Correction49
Development of a single-dose Q fever vaccine with an injectable nanoparticle-loaded hydrogel: effect of sustained co-delivery of antigen and adjuvant48
The role of lipid particle-laden interfaces in regulating the co-delivery of two hydrophobic actives from o/w emulsions47
Formulation of novel niosomal repaglinide chewable tablets using coprocessed excipients: in vitro characterization, optimization and enhanced hypoglycemic activity in rats47
Enhancement of the oral bioavailability of isopropoxy benzene guanidine though complexation with hydroxypropyl-β-cyclodextrin46
Nanoparticles-based anti-aging treatment of Alzheimer’s disease45
Development, optimization, and evaluation of a nanostructured lipid carrier of sesame oil loaded with miconazole for the treatment of oral candidiasis44
Boosting the anti MERS-CoV activity and oral bioavailability of resveratrol via PEG-stabilized emulsomal nano-carrier: Factorial design, in-vitro and in-vivo assessments44
Recent trends in platelet membrane-cloaked nanoparticles for application of inflammatory diseases44
Orally administered intelligent self-ablating nanoparticles: a new approach to improve drug cellular uptake and intestinal absorption44
SREKA-targeted liposomes for highly metastatic breast cancer therapy43
Exploring the efficacy and constraints of platinum nanoparticles as adjuvant therapy in silicosis management43
Advance in placenta drug delivery: concern for placenta-originated disease therapy43
Platinum-based drugs and hydrogel: a promising anti-tumor combination42
Boosting curcumin activity against human prostatic cancer PC3 cells by utilizing scorpion venom conjugated phytosomes as promising functionalized nanovesicles42
Celastrol-conjugated chitosan oligosaccharide for the treatment of pancreatic cancer42
Targeting interleukin-13 receptor α2 (IL-13Rα2) for glioblastoma therapy with surface functionalized nanocarriers41
Multifunctional icariin and tanshinone IIA co-delivery liposomes with potential application for Alzheimer’s disease41
Optimization of mirtazapine loaded into mesoporous silica nanostructures via Box-Behnken design: in-vitro characterization and in-vivo assessment41
0.061183929443359